SUCAMPO PHARMACEUTICALS INC's ticker is SCMP and the CUSIP is 864909106. A total of 181 filers reported holding SUCAMPO PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $4,570,000 | +1036.8% | 254,619 | +648.2% | 0.00% | – |
| Q3 2017 | $402,000 | -53.0% | 34,030 | -58.3% | 0.00% | – |
| Q2 2017 | $856,000 | -20.7% | 81,607 | -17.0% | 0.00% | -100.0% |
| Q1 2017 | $1,080,000 | +55.6% | 98,276 | +92.0% | 0.00% | – |
| Q4 2016 | $694,000 | +10.9% | 51,187 | +0.6% | 0.00% | – |
| Q3 2016 | $626,000 | +0.5% | 50,876 | -10.4% | 0.00% | – |
| Q2 2016 | $623,000 | +22.9% | 56,771 | +22.3% | 0.00% | – |
| Q1 2016 | $507,000 | +48.7% | 46,414 | +135.3% | 0.00% | – |
| Q4 2015 | $341,000 | +3310.0% | 19,727 | +4035.6% | 0.00% | – |
| Q3 2015 | $10,000 | -58.3% | 477 | -67.7% | 0.00% | – |
| Q2 2015 | $24,000 | +200.0% | 1,479 | +195.8% | 0.00% | – |
| Q1 2015 | $8,000 | – | 500 | +557.9% | 0.00% | – |
| Q3 2013 | $0 | -100.0% | 76 | -96.7% | 0.00% | – |
| Q2 2013 | $15,000 | – | 2,335 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 1,304,376 | $23,414,000 | 7.30% |
| Kassirer Asset Management Corp | 291,784 | $5,238,000 | 5.39% |
| First Trust Capital Management L.P. | 637,578 | $11,445,000 | 2.19% |
| NEXTHERA CAPITAL LP | 510,486 | $9,163,000 | 1.69% |
| HAVENS ADVISORS LLC | 100,000 | $1,795,000 | 1.35% |
| Piermont Capital Management Inc. | 172,980 | $3,105,000 | 1.02% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 674,446 | $12,106,000 | 0.97% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 1,495,600 | $26,845,000 | 0.96% |
| LONGFELLOW INVESTMENT MANAGEMENT CO LLC | 200,000 | $3,590,000 | 0.87% |
| BOOTHBAY FUND MANAGEMENT, LLC | 332,075 | $5,961,000 | 0.87% |